RT Journal Article
SR Electronic
T1 Impact of immune-related adverse events on the therapeutic efficacy of pembrolizumab in urothelial carcinoma: a multicenter retrospective study using time-dependent analysis
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e003965
DO 10.1136/jitc-2021-003965
VO 10
IS 2
A1 Kawai, Taketo
A1 Taguchi, Satoru
A1 Nakagawa, Tohru
A1 Kamei, Jun
A1 Nakamura, Yu
A1 Obinata, Daisuke
A1 Yamaguchi, Kenya
A1 Kaneko, Tomoyuki
A1 Kakutani, Shigenori
A1 Tokunaga, Mayuko
A1 Uemura, Yukari
A1 Sato, Yusuke
A1 Enomoto, Yutaka
A1 Nishimatsu, Hiroaki
A1 Fujimura, Tetsuya
A1 Fukuhara, Hiroshi
A1 Takahashi, Satoru
A1 Kume, Haruki
YR 2022
UL http://jitc.bmj.com/content/10/2/e003965.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.